MedX Health Corp
MDX.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 53.44% | -17.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 53.44% | -17.31% | |||
| Cost of Revenue | 39.06% | 15.84% | |||
| Gross Profit | 112.60% | -61.75% | |||
| SG&A Expenses | -3.59% | -24.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.18% | -19.33% | |||
| Operating Income | 5.27% | 19.51% | |||
| Income Before Tax | 2.01% | 14.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.01% | 14.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.01% | 14.53% | |||
| EBIT | 5.27% | 19.51% | |||
| EBITDA | 5.50% | 20.46% | |||
| EPS Basic | 6.06% | 19.51% | |||
| Normalized Basic EPS | 5.00% | 23.08% | |||
| EPS Diluted | 6.06% | 19.51% | |||
| Normalized Diluted EPS | 5.00% | 23.08% | |||
| Average Basic Shares Outstanding | 3.78% | 6.78% | |||
| Average Diluted Shares Outstanding | 3.78% | 6.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||